Nielsen BioSciences, Inc.   Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: San Diego CA United States (2013)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2013
NCT00690092
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Nielsen Bioscience, Inc | Nielsen BioSciences, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coccidioidomycosis (Phase 3)

Coccidiosis (Phase 3)

Papilloma (Phase 2)

Warts (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2